Skin Toxicity as Predictor of Survival in Refractory Patients with
immunotherapy
mCRC
rechallenge anti-EGFR
skin toxicity
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Nov 2021
15 Nov 2021
Historique:
received:
18
10
2021
revised:
11
11
2021
accepted:
12
11
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
The single-arm phase II CAVE mCRC trial evaluated the combination of cetuximab plus avelumab as rechallenge strategy in
Identifiants
pubmed: 34830870
pii: cancers13225715
doi: 10.3390/cancers13225715
pmc: PMC8616320
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Regione Campania
ID : (I-Cure Research Project, Grant number: Cup 21C17000030007).
Références
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597339
Nat Rev Cancer. 2006 Oct;6(10):803-12
pubmed: 16990857
J Med Life. 2015;8 Spec Issue:57-61
pubmed: 26361513
Cancer Treat Rev. 2021 Jun;97:102172
pubmed: 33989949
JAMA Oncol. 2019 Mar 1;5(3):343-350
pubmed: 30476968
J Clin Oncol. 2006 Oct 20;24(30):4914-21
pubmed: 17050875
Pharmacogenomics J. 2013 Apr;13(2):181-8
pubmed: 22158333
JAMA Oncol. 2021 Oct 1;7(10):1529-1535
pubmed: 34382998
Cancer Drug Resist. 2018;1:118-125
pubmed: 30656289
Clin Cancer Res. 2007 Jul 1;13(13):3913-21
pubmed: 17606725
ESMO Open. 2020 Sep;5(5):e000753
pubmed: 32912860
N Engl J Med. 2004 Jul 22;351(4):337-45
pubmed: 15269313
J Clin Oncol. 2005 Aug 20;23(24):5578-87
pubmed: 16009949
Cancers (Basel). 2021 Apr 17;13(8):
pubmed: 33920531
Lancet. 2013 Jan 26;381(9863):303-12
pubmed: 23177514
Sci Transl Med. 2013 Aug 21;5(199):199ra110
pubmed: 23966299
Cancer Treat Rev. 2019 Jun;76:22-32
pubmed: 31079031
Ann Oncol. 2019 Feb 1;30(2):243-249
pubmed: 30462160
Oncol Rep. 2009 Apr;21(4):1023-8
pubmed: 19288004
Oncotarget. 2016 Jul 26;7(30):47777-47793
pubmed: 27322144
Br J Cancer. 2020 Nov;123(10):1490-1495
pubmed: 32863385
Ann Oncol. 2020 Jan;31(1):72-78
pubmed: 31912799
J Clin Oncol. 2012 Aug 10;30(23):2861-8
pubmed: 22753904
Ann Oncol. 2020 Jan;31(1):30-40
pubmed: 31912793
Clin Colorectal Cancer. 2020 Sep;19(3):191-199.e6
pubmed: 32466976
Ann Oncol. 2012 Sep;23(9):2313-2318
pubmed: 22396447
ESMO Open. 2018 May 5;3(4):e000353
pubmed: 29765773
Cancer Treat Rev. 2018 Feb;63:48-60
pubmed: 29223828
Ann Oncol. 2021 Feb;32(2):157-170
pubmed: 33248228
Lancet Oncol. 2014 May;15(6):569-79
pubmed: 24739896
N Engl J Med. 2015 May 14;372(20):1909-19
pubmed: 25970050